81.70USD+4.25%Mkt Cap: 14.15B $P/E: 10.001d ago
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates throug…
Industry Peers
Medical Instruments & Supplies$142.49BUSDP/E 48.8
$84.67BUSDP/E 34.0
$73.25BUSDP/E 36.1
$44.07BUSDP/E 27.9
$31.69BUSDP/E 42.2
$29.41BUSDP/E 19.6
$25.61BUSDP/E 48.5
$19.82BUSDP/E 67.9
$18.23BUSDP/E 44.9
$18.54BUSDP/E 105.1
$14.74BUSDP/E 83.6
$13.59BUSDP/E 44.2
$14.26BUSDP/E 61.9
$12.78BUSDP/E 30.0
$12.06BUSD
$8.60BUSDP/E 23.1
$8.38BUSDP/E 165.1
$7.69BUSD
$5.63BUSDP/E 23.0
$5.99BUSDP/E 1931.7
$4.53BUSDP/E 30.5
$4.51BUSDP/E 32.6
$4.46BUSD
$4.39BUSDP/E 65.8
$4.03BUSDP/E 40.3
$4.05BUSDP/E 87.2
$3.67BUSDP/E 16.5
$3.32BUSDP/E 21.4
$3.39BUSDP/E 2759.0
$2.85BUSDP/E 21.9
$2.63BUSD
$2.77BUSD
$2.35BUSDP/E 37.9
$1.95BUSDP/E 36.0
$1.89BUSD
$1.80BUSD
$1.48BUSD
$1.44BUSD
$1.29BUSDP/E 74.9
$1.41BUSD
$1.23BUSD
$1.09BUSD
$752.64MUSDP/E 16.0
$811.83MUSD
$756.96MUSDP/E 14.8
$671.62MUSDP/E 39.2
$660.94MUSDP/E 55.9
$584.44MUSD
$360.76MUSDP/E 21.2
$354.68MUSDP/E 17.1
$272.64MUSD
$245.88MUSDP/E 13.6
$232.03MUSDP/E 422.0
$211.00MUSDP/E 35.6
$228.42MUSDP/E 21.2
$198.25MUSDP/E 23.8
$198.75MUSDP/E 1.8
$194.76MUSD
$188.63MUSDP/E 16.3
$160.12MUSD
$164.06MUSD
$123.68MUSDP/E 39.3
$115.11MUSD
$120.22MUSD
$107.50MUSD
$61.36MUSDP/E 6.4
$59.94MUSD
$48.70MUSD
$40.82MUSDP/E 53.7
$41.23MUSDP/E 41.0
$37.15MUSD
$32.43MUSD
$26.84MUSD
$25.35MUSDP/E 176.7
$20.69MUSD
$18.82MUSD
$14.75MUSD
$14.58MUSD
$13.43MUSD
$9.21MUSD
$7.52MUSDP/E 12.9
$7.46MUSD
$5.06MUSD
$4.00MUSD
$465.9KUSD
$138.6KUSD
Indicators:|
Key Statistics
Company
Market Cap14.15B $
Enterprise Value18.88B $
Revenue (TTM)8.26B $
Gross Profit4.45B $
Net Income (TTM)1.56B $
Revenue/Share47.42 USD
Last Price81.70 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees20.6K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)10.00
P/E (Forward)11.53
PEG1.22
EV/EBITDA16.80
EV/Revenue2.28
P/S1.71
P/B2.85
EPS (TTM)8.17
EPS (Forward)7.09
52W Range
62.3875% of range88.20
52W High88.20 USD
52W Low62.38 USD
Profitability
Gross Margin53.47%
Oper. Margin5.58%
EBITDA Margin13.60%
Profit Margin18.69%
ROE30.81%
ROA10.89%
Growth
Revenue Growth-3.00%
Earnings Growth-91.00%
Cash Flow & Leverage
Operating CF369.00M $
CapEx (TTM)379.00M $
FCF Margin4.57%
FCF Yield2.67%
Net Debt4.73B $
Net Debt/EBITDA4.21
Balance Sheet
Debt/Equity1.00
Current Ratio1.07
Quick Ratio0.52
Book Value/Sh28.64 USD
Cash/Share3.240 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)83.38 USD
Upside (mean)+2.1%
Target Range60.00 USD – 100.00 USD
$60.00+2.1% to mean$100.00
# Analysts13
Ownership
Shares Out.173.17M
Float147.07M
Insiders15.07%
Institutions76.12%
Short Interest
Short Ratio2.9d
Short % Float3.41%
Short % Out.2.90%
Shares Short5.02M
Short (prev mo.)7.58M
Technical
SMA 5076.54 (+6.7%)
SMA 20074.76 (+9.3%)
Beta0.72
S&P 52W Chg19.63%
Avg Vol (30d)1.02M
Avg Vol (10d)1.01M
Technical Indicators
RSI (14)63.0
MACD0.5728
MACD Signal0.3452
MACD Hist.+0.2277
BB Upper80.87 USD
BB Middle76.92 USD
BB Lower72.97 USD
BB Width10.26%
ATR (14)2.320 USD
Vol Ratio (20d)1.50x